RecruitingPhase 4NCT05929729

Iron Deficiency Anemia (IDA) and the Brain

Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia


Sponsor

Children's Hospital Los Angeles

Enrollment

120 participants

Start Date

Dec 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is a trial with an observational and an interventional arm, in patients with moderate to severe anemia and control subjects. The main purposes of this study is to phenotype the scope of neurocognitive deficits from iron deficiency anemia (IDA) in adult women, determine derangements in cerebral perfusion, vascular reactivity, functional connectivity, and blood brain barrier permeability in adult-onset IDA and relate them to neurocognitive deficits, as well as determine the reversibility and durability of both the physiologic and neurocognitive derangements by iron replacement therapy. All eligible subjects will be asked to provide informed consent before participating in the study.


Eligibility

Sex: FEMALEMin Age: 16 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ferric derisomaltose and a drug called NovaFerrum for people with anemia, anemia, iron deficiency, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include women aged 16 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFerric derisomaltose

Refer to arm/group descriptions

DRUGNovaFerrum

Refer to arm/group descriptions


Locations(4)

City of Hope Blood Donor Center

Duarte, California, United States

Cedar Sinai Blood Bank

Los Angeles, California, United States

Children's Hospital Los Angeles

Los Angeles, California, United States

University of California, Los Angeles Blood Donor Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05929729


Related Trials